Skip to main content
logo
Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
11.99
+0.40 (3.45%)
Sep 8, 2026, 11:25 AM EDT - Market open

Vicore Pharma Holding AB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
323345179158141110
Market Cap Growth
6.48%92.70%13.69%12.08%27.22%-52.33%
Enterprise Value
22825414510312461

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
783.57833.4418.13---
PB Ratio
3.672.901.763.485.072.61
P/TBV Ratio
3.672.901.763.506.633.16

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
554.41614.4614.65---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
----00.00
Net Debt / Equity Ratio
-1.06-1.06-1.02-1.06-0.90-0.97
Net Debt / EBITDA Ratio
-2.586.151.520.921.28
Net Debt / FCF Ratio
1.983.117.011.930.871.40
Asset Turnover
0.000.000.13---
Quick Ratio
12.509.9917.9011.865.695.67
Current Ratio
12.6810.2818.2012.105.815.75
Return on Equity (ROE)
-56.99%-42.92%-21.28%-83.53%-85.79%-80.37%
Return on Assets (ROA)
-34.35%-23.53%-14.05%-47.99%-45.54%-42.76%
Return on Capital Employed (ROCE)
-61.10%-41.30%-16.80%-70.20%-98.60%-76.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-16.04%-15.01%-8.51%-19.63%-19.69%-29.68%
FCF Yield
-14.72%-11.81%-8.32%-15.75%-20.47%-26.55%
Buyback Yield / Dilution
-32.83%-75.30%-41.72%-33.71%-3.64%-28.44%